Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tifuvirtide

Drug Profile

Tifuvirtide

Alternative Names: R-724; T-1249; TMC-1249

Latest Information Update: 06 Aug 2009

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Trimeris
  • Developer Monogram Biosciences; Roche; Trimeris
  • Class Amino acids; Antivirals; Peptides
  • Mechanism of Action HIV fusion inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 09 Sep 2005 ViroLogic is now called Monogram Biosciences
  • 06 Jan 2004 Suspended - Phase-I/II for HIV infections in USA (SC)
  • 18 Sep 2003 Data presented at the 43rd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the adverse events and Viral Infections therapeutic trials section ,

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top